Surface-displayed viral antigens on Salmonella carrier vaccine.
about
Emerging Applications of Bacterial Spores in NanobiotechnologyProtective immunity against influenza H5N1 virus challenge in chickens by oral administration of recombinant Lactococcus lactis expressing neuraminidase.Preparation of sticky Escherichia coli through surface display of an adhesive catecholamine moiety.Cell-Surface display of heterologous proteins: From high-throughput screening to environmental applications.Cell-surface expression of Aspergillus saitoi-derived functional α-1,2-mannosidase on Yarrowia lipolytica for glycan remodeling.Bacterial phage receptors, versatile tools for display of polypeptides on the cell surfaceDisplay of a thermostable lipase on the surface of a solvent-resistant bacterium, Pseudomonas putida GM730, and its applications in whole-cell biocatalysis.Engineered microbial biosensors based on bacterial two-component systems as synthetic biotechnology platforms in bioremediation and biorefinery.Salmonella vaccine vectors displaying delayed antigen synthesis in vivo to enhance immunogenicity.Comparative immunological evaluation of recombinant Salmonella Typhimurium strains expressing model antigens as live oral vaccines.Immunity to intracellular Salmonella depends on surface-associated antigens.Mucosal immunization with surface-displayed severe acute respiratory syndrome coronavirus spike protein on Lactobacillus casei induces neutralizing antibodies in miceAutodisplay: development of an efficacious system for surface display of antigenic determinants in Salmonella vaccine strains.Evaluation of oral immunization with recombinant avian influenza virus HA1 displayed on the Lactococcus lactis surface and combined with the mucosal adjuvant cholera toxin subunit B.Mucosal vaccination with recombinant Lactobacillus casei-displayed CTA1-conjugated consensus matrix protein-2 (sM2) induces broad protection against divergent influenza subtypes in BALB/c mice.Enteric pathogens as vaccine vectors for foreign antigen deliveryType IVB pilus operon promoter controlling expression of the severe acute respiratory syndrome-associated coronavirus nucleocapsid gene in Salmonella enterica Serovar Typhi elicits full immune response by intranasal vaccination.Molecular characterization of an ice nucleation protein variant (inaQ) from Pseudomonas syringae and the analysis of its transmembrane transport activity in Escherichia coli.Salmonella enterica serovar Typhi Ty21a expressing human papillomavirus type 16 L1 as a potential live vaccine against cervical cancer and typhoid feverAutodisplay: efficacious surface exposure of antigenic UreA fragments from Helicobacter pylori in Salmonella vaccine strainsEngineering Bacterial Surface Displayed Human Norovirus Capsid Proteins: A Novel System to Explore Interaction Between Norovirus and Ligands.Progress in Bacillus subtilis Spore Surface Display Technology towards Environment, Vaccine Development, and Biocatalysis.Improving tumor targeting and therapeutic potential of Salmonella VNP20009 by displaying cell surface CEA-specific antibodiesRetrospective analysis of a local cessation of vaccination against poliomyelitis: a possible scenario for the futureRGD Peptide Cell-Surface Display Enhances the Targeting and Therapeutic Efficacy of Attenuated Salmonella-mediated Cancer Therapy.Induction of immune responses in mice after oral immunization with recombinant Lactobacillus casei strains expressing enterotoxigenic Escherichia coli F41 fimbrial protein.Surface display of recombinant proteins on Escherichia coli by BclA exosporium of Bacillus anthracis.Adaptation of the endogenous Salmonella enterica serovar Typhi clyA-encoded hemolysin for antigen export enhances the immunogenicity of anthrax protective antigen domain 4 expressed by the attenuated live-vector vaccine strain CVD 908-htrA.Developments in high-yield system expressed vaccines and immunotherapy.Polysaccharide hydrolysis with engineered Escherichia coli for the production of biocommodities.A review of vaccine development and research for industry animals in Korea.Development of a cell surface display system in a magnetotactic bacterium, "Magnetospirillum magneticum" AMB-1.Expression and delivery of tetanus toxin fragment C fused to the N-terminal domain of SipB enhances specific immune responses in mice.Surface display of domain III of Japanese encephalitis virus E protein on Salmonella typhimurium by using an ice nucleation protein.Novel bacterial membrane surface display system using cell wall-less L-forms of Proteus mirabilis and Escherichia coliAssembly of G protein-coupled receptors onto nanosized bacterial magnetic particles using Mms16 as an anchor molecule.Export of functional Streptomyces coelicolor alditol oxidase to the periplasm or cell surface of Escherichia coli and its application in whole-cell biocatalysis.Efficient and stable display of functional proteins on bacterial magnetic particles using mms13 as a novel anchor moleculeConstruction of recombinant lactobacilli expressing the core neutralizing epitope (COE) of porcine epidemic diarrhea virus and a fusion protein consisting of COE and Escherichia coli heat-labile enterotoxin B, and comparison of the immune responseDifferent approaches to expressing Edwardsiella tarda antigen GAPDH in attenuated Vibrio anguillarum for multivalent fish vaccines.
P2860
Q24806421-77C6CD71-EE21-4F96-B483-B6757D72F584Q30373761-02DD1AC6-5F63-4A2E-AD74-F10FA5BC5787Q30435518-A6E60EB4-E966-485B-B1B2-0785CE34EE0FQ31107604-2D1904D8-74B1-49DE-80EF-B0C94890E641Q31128321-3570487B-129B-4E74-ADE9-949D86221A4AQ32031181-0B183292-1814-4467-8CD3-9F51CD34BED7Q33240174-F43A2C00-8929-47E8-8454-F5FB4DE10921Q33564662-19C5EF3D-E3DA-4D37-A691-122E474F0D34Q34119481-425E8F6B-BDC9-4FEB-AF9C-FACC90118AB5Q34421752-7C3C0561-DDFF-4327-B8DA-8EB4B9E5E800Q34456080-C65ADF97-3E3D-40C7-8767-227DCBE5D9B0Q34545911-1AB16576-9F17-40CB-A7F1-DB75B37825C5Q34851811-F26199E8-EC78-48FB-9255-186B25C60CEAQ35138652-C5D69F5E-CFF3-4A03-8C0B-719AF97A36C4Q35142923-2C7CD86B-EF30-43B1-96ED-03DEB6E94174Q35896020-0477A1AB-E09E-4C6E-9382-EE4E52FC87F7Q36097106-8CDFFD75-5987-4486-9133-AB58AB997317Q36241960-BF127CDB-F466-45F1-BDAB-25448FFCA861Q36313476-8F1689FC-0509-45BA-BB36-08BBA15EF27EQ36374944-6442D2B7-AB2C-4056-9F3F-B670F8324204Q36391936-C0E7957A-DD96-4313-926D-CD0505F4E4CDQ36399441-54DA839D-4975-419F-95CB-E305951FA608Q36949433-B11D7AF3-2E7E-457E-8834-E23A97F01D19Q37060273-8F64A519-CC3E-4958-8C5A-704BC68DD13CQ37112974-57FD42A4-55CC-40DD-A213-DC2D991249F0Q37248099-F5A7C45E-0B45-43C4-B3AC-F57E997679AEQ37363035-5060091E-88B9-4900-8161-32223B985A1FQ37623663-95A8EDDC-031C-48B0-B662-1AB42EFF83D5Q37822474-618626EF-E03F-4BBC-B5A5-ABC966938CF1Q38088166-80ED1820-0F2A-49D9-8AE2-B0857012C6F2Q38099839-6DA4640E-DC69-4765-938D-9A658D6AFBCAQ39022898-F56FFEA8-B1B7-43A0-AA96-8CDC1C32E468Q39329419-2432CEE5-C7EC-4CDB-B838-CF7A96E1BDBFQ39429601-C4CFD071-B208-4EB7-BAF6-A204B1FD94AFQ39649704-96E20C5E-7A86-4CA7-B0D8-8245495872BBQ40832997-ABDD37BE-7886-4C78-9C20-6490FBB514AEQ42106044-E4BAE9BD-09BC-46BE-B0BE-8BF99A2C3803Q42122347-FCD02471-54A6-47BD-AF63-2D610B9A2B9FQ42286868-A2CF8A22-68D9-40BE-855F-905E6D8E9032Q43406367-DB261A87-0030-4758-A32D-6BADA0FAC449
P2860
Surface-displayed viral antigens on Salmonella carrier vaccine.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh-hant
name
Surface-displayed viral antigens on Salmonella carrier vaccine.
@en
Surface-displayed viral antigens on Salmonella carrier vaccine.
@nl
type
label
Surface-displayed viral antigens on Salmonella carrier vaccine.
@en
Surface-displayed viral antigens on Salmonella carrier vaccine.
@nl
prefLabel
Surface-displayed viral antigens on Salmonella carrier vaccine.
@en
Surface-displayed viral antigens on Salmonella carrier vaccine.
@nl
P2860
P356
P1433
P1476
Surface-displayed viral antigens on Salmonella carrier vaccine
@en
P2860
P2888
P304
P356
10.1038/76494
P577
2000-06-01T00:00:00Z